Labor induction in preeclampsia: Is misoprostol more effective than dinoprostone?

Journal of Perinatal Medicine

Volumn 35, Issue 3, 2007, Pages 195-199

  Lapaire, Olav ^a   Zanetti Dällenbach, Rosanna ^a   Weber, Patrizia ^a   Hösli, Irene ^a   Holzgreve, Wolfgang ^a   Surbek, Daniel ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dinoprostone; Induction of labor; Misoprostol; Preeclampsia

Indexed keywords

MAGNESIUM SULFATE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2;

ADULT; ARTICLE; CESAREAN SECTION; CHEMOPROPHYLAXIS; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG EFFICACY; FEMALE; FETUS OUTCOME; HUMAN; HYPERSTIMULATION SYNDROME; LABOR COMPLICATION; LABOR INDUCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; OPTIMAL DRUG DOSE; PREECLAMPSIA; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK; STATISTICAL SIGNIFICANCE; SUPPOSITORY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UTERINE CERVIX RIPENING; VAGINAL DELIVERY; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, INTRAVAGINAL; ADULT; DINOPROSTONE; FEMALE; HUMANS; LABOR, INDUCED; MEDICAL RECORDS; MISOPROSTOL; OXYTOCICS; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247863723     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2007.028     Document Type: Article

References (22)

1. ACOG Committee Opinion: Number 283, May 2003. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy. Obstet Gynecol. 2003;101:1049-50.
2. Clinical effectiveness support unit. The use of electronic fetal monitoring. The use of cardiotocography in intrapartum fetal surveillance. Evidence-based clinical guideline number 8. London: RCOG Press; 2001.
3. Danelian P, Poter B, Ferri N, Summers J, Templeton A. Misoprostol for induction of labour at term: a more effective agent than dinoprostone gel. Br J Obstet Gynaecol. 1999;106:793-7.
4. Del Valle GO, Sanchez-Ramos L, Jordan CW, Gaudier FL, Delke I. Use of misoprostol to expedite delivery in severe preeclampsia remote from term. J Matern Fetal Med. 1996;5:39-40.
5. Griffiths AN, Hikary N, Sizer AR. Induction to delivery time interval in patients with and without preeclampsia: a retrospective analysis. Acta Obstet Gynecol Scand. 2002;81:867-9.
6. Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labor: a systematic review. Br J Obstet Gynaecol. 1999;106:798-803.
7. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane database Syst Rev 2003 CD000941.
8. Mercer BM. Induction of labor in the nulliparous gravida with an unfavorable cervix. Obstet Gynecol. 2005;105:688-9.
9. Nahar S, Rasul CH, Sayed A, Azim A. Utility of misoprostol for labor induction in severe pre-eclampsia and eclampsia. J Obstet Gynaecol Res. 2004;30:349-53.
10. Park KH, Cho YK, Lee CM, Choi H, Kim BR, Lee HK. Effect of preeclampsia, magnesium and maternal weight on labor induction: a retrospective analysis. Gynecol Obstet Invest. 2006;61:40-4.
11. Ramsey PS, Meyer L, Walkes BA, Harris D, Ogburn PL Jr, Heise RH, et al. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstet Gynecol. 2005;105:85-90.
12. Sahin HG, Sahin HA, Surucu R, Guvercinci M. A study of intravaginal misoprostol for induction of labor in toxemia of pregnancy. Int J Gynecol Obstet. 2001;75:3-9.
13. Sanchez-Ramos L, Kaunitz AM, Delke I. Labor induction with 25 mg versus 50 mg intravaginal misoprostol: a systematic review. Obstet Gynecol. 2002;99:145-51.
14. Shetty A, Danielian P, Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. Br J Obstet Gynaecol. 2001;108:238-43.
15. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172:642-8.
16. Surbek D, Boesiger H, Hoesli I, Pavic N, Holzgreve W. A double-blind comparison of the safety and efficacy of intravaginal misoprostol and prostaglandin E2 to induce labor. Am J Obstet Gynecol. 1997;177:1018-23.
17. Szal SE, Croughan-Minihane MS, Kilpatrick SJ. Effect of magnesium prophylaxis and preeclampsia on the duration of labor. Am J Obstet Gynecol. 1999;180:1475-9.
18. Szczesny W, Kjollesdal M, Karlsson B, Nielsen S. Bishop score and the outcome of labor induction with misoprostol. Acta Obstet Gynecol Scand. 2006;85:579-82.
19. Wing DA. Labor induction with misoprostol. Am J Obstet Gynecol. 1999;181:339-45.
20. Wing DA, Tran S, Paul RH. Factors affecting the likelihood of successful induction after intravaginal misoprostol application for cervical ripening and labor induction. Am J Obstet Gynecol. 2002;186:1237-40.
21. Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, doubleblind, placebo-controlled trial. Am J Obstet Gynecol. 1997;177:1561-2.
22. Xenacis EM, Piper J, Field N, Conway D, Langer O. Preeclampsia: Is induction of labor more successful? Obstet Gynecol. 1997;89:600-3.